Skip to contentD
Dare Bioscience, Inc.
D
DAREDare Bioscience, Inc. Q1 2020 · 10-Q
Revenue—
Net Income-$4.25M-$4.25MN/M vs Q1 2019 EPS Diluted-$0.18-$0.18N/M vs Q1 2019 Operating Income-$4,254,069N/M Operating Cash Flow-$6,597,546N/M
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Dare Bioscience, Inc. · CIK 1401914 · Engraved from SEC EDGAR
ended Mar 31, 2020 · filed May 14, 2020 · 44 d after period end